Opinions

Dementia 12 January 2026

Nanoparticles in Alzheimer’s disease: a new frontier in diagnosis and therapy

Dementia represents one of the greatest public health challenges of our time. It encompasses a range of neurodegenerative disorders marked by progressive cognitive decline, memory loss and loss of independence. Among these diseases, Alzheimer’s disease (AD) is the most prevalent, accounting for approximately 60–70% of all dementia cases worldwide.

Lead image 2025 12 09 T113434 970

The uncomfortable truth about alcohol

Despite reductions in consumption, particularly among young people, Australia has seen a rise in alcohol-related harms and avoidable costs. To decrease alcohol’s enormous burden on individuals, families and communities, it is important that all drinkers ease their alcohol consumption, not just heavy drinkers and other risk groups.

Lead image 2025 12 09 T090421 817
Cancer 8 December 2025

Lung cancer screening will uncover more than cancer. Are we prepared?

The launch of Australia’s National Lung Cancer Screening Program (NLCSP) is a step forward in preventive healthcare — but screening thousands of high-risk Australians with low-dose CT scans will inevitably uncover a far greater number of people with undiagnosed chronic respiratory disease, particularly chronic obstructive pulmonary disease (COPD).

Lead image 2025 12 04 T100837 795
Prescribing 8 December 2025

Exploring a new medicines management framework

Despite ongoing efforts to improve the communication of medicines information across the health system, medication errors at transitions of care persist. Each year in Australia, 250 000 hospital admissions are due to medication-related errors, costing our healthcare system an estimated $1.4 billion. More than half of medication errors occur at transitions of care.

Lead image 2025 12 04 T101418 424